CCL2 and cardiovascular disorder: In conclusion, a wealth of animal and human research has provided evidence that the CCL2-CCR2 axis is important in the progression of cardiovascular disease, and the success of pharmacological targeting studies of the CCL2-CCR2 axis holds promise for a gradual transition to clinical trials.